valerates has been researched along with Hyperinsulinism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Awady, MS; Gameil, NM; Megahed, N; Sharawy, MH | 1 |
| Gerlinger-Romero, F; Giannocco, G; Guimarães-Ferreira, L; Nunes, MT | 1 |
2 other study(ies) available for valerates and Hyperinsulinism
| Article | Year |
|---|---|
The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver.
Topics: Animals; Dietary Carbohydrates; Dietary Supplements; Endothelium, Vascular; Fructose; Gene Expression Regulation; Glucose Intolerance; Glucose Transporter Type 2; Hyperinsulinism; Hyperlipidemias; Insulin Resistance; Liver; Male; Non-alcoholic Fatty Liver Disease; Performance-Enhancing Substances; PPAR alpha; Random Allocation; Rats, Sprague-Dawley; Sterol Regulatory Element Binding Protein 1; TOR Serine-Threonine Kinases; Valerates; Vascular Resistance | 2016 |
Chronic supplementation of beta-hydroxy-beta methylbutyrate (HMβ) increases the activity of the GH/IGF-I axis and induces hyperinsulinemia in rats.
Topics: Animals; Growth Hormone; Hyperinsulinism; Insulin-Like Growth Factor I; Male; Muscle, Skeletal; Myostatin; Rats; Rats, Wistar; RNA, Messenger; Valerates | 2011 |